ROLE OF THE SPANISH AGENCY FOR MEDICINES AND MEDICAL DEVICES (AEMPS) IN THE ASSESSMENT OF CENTRALISED MEDICINAL PRODUCTS

被引：0
|
作者：
Alonso-Gutierrez, A. [1 ]
Sulleiro-Avendano, E. [1 ]
Padilla-Gallego, M. E. [1 ]
Diaz-Ramos, P. [1 ]
机构：
[1] Agencia Espanola Medicamentos & Prod Sanitarios, Madrid, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [31] The European Medicines Agency Review of Pazopanib for the Treatment of Advanced Renal Cell Carcinoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
    Nieto, Maria
    Borregaard, Jeanett
    Ersboll, Jens
    ten Bosch, George J. A.
    van Zwieten-Boot, Barbara
    Abadie, Eric
    Schellens, Jan H. M.
    Pignatti, Francesco
    CLINICAL CANCER RESEARCH, 2011, 17 (21) : 6608 - 6614
  • [32] Preparing Europe for future health threats and crises - the European Medicines Agency; ensuring safe and effective medicines and medical devices
    Cooke, Emer
    EUROSURVEILLANCE, 2022, 27 (42)
  • [33] Adverse Drug Reactions of Hydroxymethylglutaryl-CoA Reductase Inhibitors Related to the Administered Dose Reported to the Agency for Medicinal Products and Medical Devices
    Bozina, N.
    Mirosevic, N.
    Sarinic, V. Macolic
    Tomic, S.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (05): : 325 - 325
  • [34] New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus
    van der Schueren, Bart
    Vrijlandt, Patrick
    Thomson, Andrew
    Janssen, Heidi
    Dunder, Kristina
    DIABETOLOGIA, 2024, 67 (07) : 1159 - 1162
  • [35] The European Medicines Agency Review of Bosutinib for the Treatment of Adult Patients With Chronic Myelogenous Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
    Hanaizi, Zahra
    Unkrig, Christoph
    Enzmann, Harald
    Camarero, Jorge
    Sancho-Lopez, Arantxa
    Salmonson, Tomas
    Gisselbrecht, Christian
    Laane, Edward
    Pignatti, Francesco
    ONCOLOGIST, 2014, 19 (04): : 421 - 425
  • [36] Debate of the legal interpretation of definitions of medical devices and medicinal products for human use
    Ferge Zsigmond
    ORVOSI HETILAP, 2014, 155 (11) : 429 - 433
  • [37] Systematic review for development of a medicinal products and medical devices prioritization framework.
    Frutos Perez-Surio, Alberto
    Gimeno-Gracia, Mercedes
    Aranzazu Alcacera-Lopez, Maria
    Asuncion Sagredo-Samanes, Ma
    del Puerto Pardo-Jario, Ma
    del Transito Salvador-Gomez, Ma
    PHARMACOTHERAPY, 2018, 38 (07): : E77 - E77
  • [38] Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study
    Skvrce, Nikica Miroevic
    Sarinic, Viola Macolic
    Mucalo, Iva
    Krnic, Darko
    Bozina, Nada
    Tomic, Sinisa
    CROATIAN MEDICAL JOURNAL, 2011, 52 (05) : 604 - 614
  • [39] The classification of antiseptic products to be administered to wounds -: another borderline case between medicinal products and medical devices?
    Kramer, A.
    Kremer, J.
    Assadian, O.
    Schneider, I.
    Daehne, H.
    Schwemmer, J.
    Mueller, G.
    Siegmund, W.
    Jaekel, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2006, 44 (12) : 677 - 692
  • [40] The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
    Nieto, Maria
    Demolis, Pierre
    Behanzin, Eliane
    Moreau, Alexandre
    Hudson, Ian
    Flores, Beatriz
    Stemplewski, Henry
    Salmonson, Tomas
    Gisselbrecht, Christian
    Bowen, David
    Pignatti, Francesco
    ONCOLOGIST, 2016, 21 (06): : 692 - 700
12345